Modeling thrombin generation: Plasma composition based approach

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 1, 2014, Pages 32-44

  Brummel Ziedins, Kathleen E ^a   Everse, Stephen J ^a   Mann, Kenneth G ^a   Orfeo, Thomas ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Computational modeling; Plasma composition; Thrombin; Thrombin phenotypes

Indexed keywords

ANIMALS; BLOOD COAGULATION; HEMOSTASIS; HUMANS; MODELS, MOLECULAR; PLASMA; THROMBIN;

EID: 84895072761     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1006-9     Document Type: Review

References (129)

1. Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH (2010) Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 38:S502-S509
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123:e18-e209
3. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123:933-944
4. Mann KG, Orfeo T, Butenas S, Undas A, Brummel-Ziedins K (2009) Blood coagulation dynamics in haemostasis. Hamostaseologie 29:7-16
5. Anderson JA, Weitz JI (2010) Hypercoagulable states. Clin Chest Med 31:659-673
6. Heit JA (2007) Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 1:127-135
7. Fraser JS, Gross JD, Krogan NJ (2013) From systems to structure: bridging networks and mechanism. Mol Cell 49:222-231
8. Chakrabarti A, Miskovic L, Soh KC, Hatzimanikatis V (2013) Towards kinetic modeling of genome-scale metabolic networks without sacrificing stoichiometric, thermodynamic and physiological constraints. Biotechnol J 8:1043-1057
9. Hockin MF, Jones KC, Everse SJ, Mann KG (2002) A model for the stoichiometric regulation of blood coagulation. J Biol Chem 277:18322-18333
10. Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI (2006) Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 90:1489-1500
11. Luan D, Zai M, Varner JD (2007) Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. PLoS Comput Biol 3:e142
12. Anand M, Rajagopal K, Rajagopal KR (2008) A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. J Theor Biol 253:725-738
13. Chatterjee MS, Denney WS, Jing H, Diamond SL (2010) Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 6:e1000950
14. Mitrophanov AY, Reifman J (2011) Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 128:381-390
15. Hall CL, Slack SM, Turitto VT (1998) A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells. Ann Biomed Eng 26:28-36
16. Kuharsky AL, Fogelson AL (2001) Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J 80:1050-1074
17. Ataullakhanov FI, Panteleev MA (2005) Mathematical modeling and computer simulation in blood coagulation. Pathophysiol Haemost Thromb 34:60-70
18. Fogelson AL, Tania N (2005) Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb 34:91-108
19. Runyon MK, Kastrup CJ, Johnson-Kerner BL, Ha TG, Ismagilov RF (2008) Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations. J Am Chem Soc 130:3458-3464
20. Xu Z, Christley S, Lioi J, Kim O, Harvey C, Sun W, Rosen ED, Alber M (2012) Multiscale model of fibrin accumulation on the blood clot surface and platelet dynamics. Methods Cell Biol 110:367-388
21. Neeves KB, Illing DA, Diamond SL (2010) Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 98:1344-1352
22. Neeves KB, Onasoga AA, Wufsus AR (2013) The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. Curr Opin Hematol 20:417-423
23. Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG (2004) The significance of circulating factor IXa in blood. J Biol Chem 279:22875-22882
24. Bravo MC, Orfeo T, Mann KG, Everse SJ (2012) Modeling of human factor Va inactivation by activated protein C. BMC Syst Biol 6:45
25. Brummel-Ziedins KE, Orfeo T, Callas PW, Gissel M, Mann KG, Bovill EG (2012) The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. PLoS ONE 7:e44378
26. Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG (2010) Anticoagulation by factor Xa inhibitors. J Thromb Haemost 8:1745-1753
27. Brummel-Ziedins KE, Pouliot RL, Mann KG (2004) Thrombin generation: phenotypic quantitation. J Thromb Haemost 2:281-288
28. Crawley JT, Zanardelli S, Chion CK, Lane DA (2007) The central role of thrombin in hemostasis. J Thromb Haemost 5(Suppl 1):95-101
29. Hemker HC, Beguin S (2000) Phenotyping the clotting system. Thromb Haemost 84:747-751
30. Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG (2005) The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost 3:1472-1481
31. Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR (2005) Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 3:2497-2505
32. Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG (2008) Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 6:104-110
33. Brummel-Ziedins KE, Orfeo T, Rosendaal FR, Undas A, Rivard GE, Butenas S, Mann KG (2009) Empirical and theoretical phenotypic discrimination. J Thromb Haemost 7(Suppl 1):181-186
34. Brummel-Ziedins KE, Whelihan MF, Gissel M, Mann KG, Rivard GE (2009) Thrombin generation and bleeding in haemophilia A. Haemophilia 15:1118-1125
35. Brummel-Ziedins KE, Orfeo T, Gissel M, Mann KG, Rosendaal FR (2012) Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. PLoS ONE 7:e29178
36. Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ (2013) Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coron Artery Dis 24:468-474
37. Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, Dehovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP (2013) HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2:e000264
38. Brummel-Ziedins K (2013) Models for thrombin generation and risk of disease. J Thromb Haemost 11(Suppl 1):212-223
39. Mann KG, Brummel K, Butenas S (2003) What is all that thrombin for? J Thromb Haemost 1:1504-1514
40. Xue J, Wu Q, Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95:7603-7607
41. Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW 2nd (1984) Localization of a chemotactic domain in human thrombin. Biochemistry 23:397-400
42. Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD (1986) Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976-980
43. Morawitz P (1905) Die chemie der blutgerrinnung. Ergebn Physiol. 4:307
44. Fuld E, Spiro K (1904) Der einflup einiger gerrinnungshemmender agentien auf das Vogel plasma. Beitr z Chem Phys u Path (Hofmeister's) 5:171
45. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023-11027
46. Tracy PB (1988) Regulation of thrombin generation at cell surfaces. Semin Thromb Hemost 14:227-233
47. Bouchard BA, Tracy PB (2001) Platelet regulation of thrombin generation in cardiovascular disease. Italian Heart J 2:819-823
48. Mosesson MW (1992) The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 29:177-188
49. Spraggon G, Everse SJ, Doolittle RF (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455-462
50. Hantgan R, McDonagh J, Hermans J (1983) Fibrin assembly. Ann NY Acad Sci 408:344-366
51. Lorand L, Jeong JM, Radek JT, Wilson J (1993) Human plasma factor XIII: subunit interactions and activation of zymogen. Method Enzymol 222:22-35
52. Lorand L, Konishi K (1964) Activation of the fibrin-stabilizing factor of plasma by thrombin. Arch Biochem Biophys 105:58
53. Yee VC, Pedersen LC, Le TI, Bishop PD, Stenkamp RE, Teller DC (1994) Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296-7300
54. Bajzar L, Manuel R, Nesheim ME (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477-14484
55. Bajzar L, Morser J, Nesheim M (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271:16603-16608
56. Mann KG, Jenny RJ, Krishnaswamy S (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 57:915-956
57. Fay PJ (1988) Subunit structure of thrombin-activated human factor VIIIa. Biochim Biophys Acta 952:181-190
58. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG (1987) Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846-4850
59. Lollar P, Parker CG (1989) Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 28:666-674
60. Radcliffe R, Nemerson Y (1975) Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem 250:388-395
61. Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946-955
62. Mann KG (2011) Thrombin generation in hemorrhage control and vascular occlusion. Circulation 124:225-235
63. Esmon CT (2003) The protein C pathway. Chest 124:26S-32S
64. Kalafatis M, Egan JO (1997) van 't Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr 7:241-280
65. Olson ST, Shore JD (1982) Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257:14891-14895
66. Parker KA, Tollefsen DM (1985) The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. J Biol Chem 260:3501-3505
67. Harpel PC (1970) Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein. J Exp Med 132:329-352
68. Brummel KE, Paradis SG, Butenas S, Mann KG (2002) Thrombin functions during tissue factor-induced blood coagulation. Blood 100:148-152
69. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG (1996) Blood clotting in minimally altered whole blood. Blood 88:3432-3445
70. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC (2002) The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 88:576-582
71. Dargaud Y, Beguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, Hemker HC, Negrier C (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 93:475-480
72. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249-253
73. Regnault V, Hemker HC, Wahl D, Lecompte T (2004) Phenotyping the haemostatic system by thrombography - potential for the estimation of thrombotic risk. Thromb Res 114:539-545
74. Allen GA, Hoffman M, Roberts HR, Monroe DM (2006) Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 134:314-319
75. Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arterioscler Thromb Vasc Biol 27:683-689
76. Van't Veer C, Golden NJ, Mann KG (2000) Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood 95:1330-1335
77. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG (2002) Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 99:923-930
78. Gissel M, Whelihan MF, Ferris LA, Mann KG, Rivard GE, Brummel-Ziedins KE (2012) The influence of prophylactic factor VIII in severe haemophilia A. Haemophilia 18:193-199
79. Cawthern KM, van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG (1998) Blood coagulation in hemophilia A and hemophilia C. Blood 91:4581-4592
80. Brummel-Ziedins KE, Whelihan MF, Rivard GE, Butenas S (2011) Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1. J Thromb Haemost 9:2262-2267
81. Poort SR, Michiels JJ, Reitsma PH, Bertina RM (1994) Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 72:819-824
82. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
83. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, Druschky KF, Patscheke H (1998) Prothrombin gene G20210 ≥ A transition is a risk factor for cerebral venous thrombosis. Stroke 29:1765-1769
84. Margaglione M, Brancaccio V, Giuliani N, D'Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G (1998) Increased risk for venous thrombosis in carriers of the prothrombin G ≥ A20210 gene variant. Ann Intern Med 129:89-93
85. Quick AJ, Stanley-Brown M, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501
86. Owren PA, Aas K (1951) The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 3:201-208
87. Langdell RD, Wagner RH, Brinkhous KM (1953) Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med 41:637-647
88. Nair SC, Dargaud Y, Chitlur M, Srivastava A (2010) Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 16(Suppl 5):85-92
89. Young G, Sorensen B, Dargaud Y, Negrier C, Brummel-Ziedins K, Key NS (2013) Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state-of-art and future perspectives. Blood. 121:1944-1950
90. van Geffen M, van Heerde WL (2012) Global haemostasis assays, from bench to bedside. Thromb Res 129:681-687
91. Hemker HC (2005) Calibrated automated thrombinography (CAT). Thromb Res 115:255
92. Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T (2012) Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 58:1252-1259
93. Hartert H (1948) Not Available. Klinische Wochenschrift 26:577-583
94. Lawson JH, Kalafatis M, Stram S, Mann KG (1994) A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357-23366
95. Butenas S, van't Veer C, Mann KG (1999) Normal thrombin generation. Blood 94:2169-2178
96. Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V (2010) Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol 30:376-381
97. Foley JH, Orfeo T, Undas A, McLean KC, Bernstein IM, Rivard GE, Mann KG, Everse SJ, Brummel-Ziedins KE (2013) From principle to practice: bridging the gap in patient profiling. PLoS ONE 8:e54728
98. Danforth CM, Orfeo T, Everse SJ, Mann KG, Brummel-Ziedins KE (2012) Defining the boundaries of normal thrombin generation: investigations into hemostasis. PLoS ONE 7:e30385
99. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33:4-15
100. Dargaud Y, Francillon S, Negrier C (2009) Intraindividual thrombin generation measurement variability in healthy adults over a 1 year period. Thromb Res 124:237-238
101. Haidl H, Cimenti C, Leschnik B, Zach D, Muntean W (2006) Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 95:772-775
102. McLean KC, Bernstein IM, Brummel-Ziedins KE (2012) Tissue factor-dependent thrombin generation across pregnancy. Am J Obstet Gynecol 207(135):e1-e6
103. Dargaud Y, Hierso S, Rugeri L, Battie C, Gaucherand P, Negrier C, Trzeciak MC (2010) Endogenous thrombin potential, prothrombin fragment 1 + 2 and d-dimers during pregnancy. Thromb Haemost 103:469-471
104. Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K, Kyrle PA (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 82:1232-1236
105. Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M (1999) APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 81:527-531
106. Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J (2002) Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 88:5-11
107. Rosenkranz A, Hiden M, Leschnik B, Weiss EC, Schlembach D, Lang U, Gallistl S, Muntean W (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99:331-337
108. Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK (1995) Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 27:1465-1470
109. Weiss C, Seitel G, Bartsch P (1998) Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 30:246-251
110. Weiss C, Velich T, Niebauer J, Hauer K, Kalberer B, Kubler W, Bartsch P (1998) Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease. Am J Cardiol 81:672-677
111. Cimenti C, Schlagenhauf A, Leschnik B, Schretter M, Tschakert G, Groschl W, Seibert FJ, Hofmann P, Muntean WE (2013) Low endogenous thrombin potential in trained subjects. Thromb Res 131:e281-e285
112. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85:3144-3149
113. Sagripanti A, Carpi A (1998) Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 33:891-896
114. Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33:428-432
115. Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153-168
116. O'Donnell J, Mumford AD, Manning RA, Laffan MA (2001) Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 115:687-691
117. Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM (2009) An imbalance of pro- versus anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105-2111
118. Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR, Monroe DM (2004) Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2:402-413
119. Xi M, Beguin S, Hemker HC (1989) The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 62:788-791
120. Brummel-Ziedins KE, Branda RF, Butenas S, Mann KG (2009) Discordant fibrin formation in hemophilia. J Thromb Haemost 7:825-832
121. Brummel Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG (2004) Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2:1735-1744
122. Brummel-Ziedins K, Callas PW, Orfeo T, Gissel M, Hockin MF, Mann KG, Bovill EG (2009) Evaluating thrombin generation in a family with protein C deficiency. J Thromb Haemost 7:162-163
123. Foley JH, Ferris L, Brummel-Ziedins KE (2012) Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency. Thromb Res 129:e142-e146
124. Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24-e28
125. Gissel M, Undas A, Slowik A, Mann KG, Brummel-Ziedins KE (2010) Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res 126:262-269
126. Undas A, Gissel M, Kwasny-Krochin B, Gluszko P, Mann KG, Brummel-Ziedins KE (2010) Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 104:224-230
127. Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG (2009) The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization. Thromb Res 124:505-507
128. Danforth CM, Orfeo T, Mann KG, Brummel-Ziedins KE, Everse SJ (2009) The impact of uncertainty in a blood coagulation model. Math Med Biol 26:323-336
129. Aleman MM, Walton BL, Byrnes JR, Wang JG, Heisler MJ, Machlus KR, Cooley BC, Wolberg AS (2013) Elevated prothrombin promotes venous, but not arterial, thrombosis in mice. Arterioscler Thromb Vasc Biol 33:1829-1836